Crystal structure of Ce(IV)/dipicolinate complex as catalyst for DNA hydrolysis

Targeting Killing of Tumor Cells Based on Isoelectric Point Suitable Nanoceria-rod with High Oxygen Vacancies

Nanozymes have great potential application in tumor treatment because of their good stability, high biocompatibility, easy preparation and versatility. However, it remains a challenge to design of highly active nanozyme...

Cerium oxide nanoparticles: properties, biosynthesis and biomedical application

Cerium oxide nanoparticles have revolutionized the biomedical field and is still in very fast pace of development. Hence, this work elaborates the physicochemical properties, biosynthesis, and biomedical applications of cerium oxide nanoparticles.

Pyridine-2,6-Dicarboxylic Acid Esters (pydicR2) as O,N,O-Pincer Ligands in CuII Complexes

The pyridine-2,6-carboxylic esters pydicR2 with R = Me or Ph form the unprecedented mononuclear CuII complexes [Cu(pydicR2)Cl3]− in one-pot reactions starting from pyridine-2,6-carboxychloride pydicCl2, CuII chloride, and NEt3 in MeOH or PhOH solution under non-aqueous conditions. The triethylammonium salts (HNEt3)[Cu(pydicR2)Cl3] were isolated. The methyl derivative could be crystallized to allow a XRD structure determination. Both structures were optimized using DFT calculations in various surroundings ranging from gas phase and the non-coordinating solvent CH2Cl2 to the weakly coordinating acetone and well-coordinating solvents acetonitrile (MeCN) or dimethylformamide (DMF), while detailed calculation showed the charge distribution, dipole moments, and HOMO–LUMO gap energies changing upon solvation. According to these calculations, the ion pairs and the anionic CuII complexes were stable, which shows only Cu–Cl bond elongation and weakening of the charge transfer between the anionic complex and the cation as solvents become polar. Synthesis attempts in the presence of water yielded the CuII complexes [Cu(pydic)(OH2)2]n and [Cu(OH2)6][{Cu(pydic)}2(µ-Cl)2], which results from pydicCl2 hydrolysis. Alternatively, the new pydic(IPh)2 (IPh = 2-iodo-phenyl) ester ligand was synthesized and reacted with anhydrous CuCl2, which yields the new binuclear complex [{Cu(pydic(IPh)2)Cl}2(µ-Cl)2]. EPR spectroscopy of the solid compounds reveals typical axial spectra in line with the observed and DFT calculated geometries. Cyclic voltammetry and UV–vis absorption spectroscopy in solution are in line with un-dissociated complex species [Cu(pydicR2)Cl3]−.

Catalytic Capacity of Diaza-Crown Ether Lanthanum Complexes with Varied Ligands for Phosphate Ester Hydrolysis in Different Media

Two diaza-crown ether compounds, 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane (L0) and its derivative with double acetamide side arms 2,2'-(1,4,10,13-teteaoxa-7,16-diazacyclooctadecane-7,16-diyl)diacetamide (L), and the corresponding two lanthanum complexes were synthesised and characterised. The catalytic capacity of the lanthanum complexes was investigated for the hydrolysis of bis(4-nitrophenyl) phosphate ester (BNPP) in aqueous solution and in CTAB micelles. Kinetic studies show that the catalytic efficiency of complex LaL is obviously higher than that of complex LaL0, and introducing acetamide into the ring of the diaza-crown ether can improve the catalytic ability of the complexes for BNPP hydrolysis. A rate enhancement of about two times was observed for the complex–micelle in contrast with the complex–water system for BNPP catalytic hydrolysis. The optimal pH for the catalytic reaction in the two kinds of media systems show an approximately 0.4 pH unit difference. The two complexes possess higher thermostability, and are more stable in the micelle than in aqueous solution. Based on the results and their analysis, a catalytic mechanism with cooperation of acetamide is proposed.

Phosphate Ester Bond Hydrolysis Promoted by Lanthanide-Substituted Keggin-type Polyoxometalates Studied by a Combined Experimental and Density Functional Theory Approach

Hydrolytic cleavage of 4-nitrophenyl phosphate (NPP), a commonly used DNA model substrate, was examined in the presence of series of lanthanide-substituted Keggin-type polyoxometalates (POMs) [Me₂NH₂]₁₁[Ce^III(PW₁₁O₃₉)₂], [Me₂NH₂]₁₀[Ce^IV(PW₁₁O₃₉)₂] (abbreviated as (Ce^IV(PW₁₁)₂), and K₄[EuPW₁₁O₃₉] by means of NMR and luminescence spectroscopies and density functional theory (DFT) calculations. Among the examined complexes, the Ce(IV)-substituted Keggin POM (Ce^IV(PW₁₁)₂) showed the highest reactivity, and its aqueous speciation was fully determined under different conditions of pD, temperature, concentration, and ionic strength by means of ³¹P and ³¹P diffusion-ordered NMR spectroscopy. The cleavage of the phosphoester bond of NPP in the presence of (Ce^IV(PW₁₁)₂) proceeded with an observed rate constant k_obs = (5.31 ± 0.06) × 10^-6 s^-1 at pD 6.4 and 50 °C. The pD dependence of NPP hydrolysis exhibits a bell-shaped profile, with the fastest rate observed at pD 6.4. The formation constant (K_f = 127 M^-1) and catalytic rate constant (k_c = 19.41 × 10^-5 s^-1) for the NPP-Ce(IV)-Keggin POM complex were calculated, and binding between Ce^IV(PW₁₁)₂ and the phosphate group of NPP was also evidenced by the change of the chemical shift of the ³¹P nucleus in NPP upon addition of the POM complex. DFT calculations revealed that binding of NPP to the parent catalyst Ce^IV(PW₁₁)₂ is thermodynamically unlikely. On the contrary, formation of complexes with the monomeric 1:1 species, Ce^IVPW₁₁, is considered to be more favorable, and the most stable complex, [Ce^IVPW₁₁(H₂O)₂(NPP-κO)₂]^7-, was found to involve two NPP ligands coordinated to the Ce^IVcenter of Ce^IVPW₁₁ in the monodentate fashion. The formation of such species is considered to be responsible for the hydrolytic activity of Ce^IV(PW₁₁)₂ toward phosphomonoesters. On the basis of these findings a principle mechanism for the hydrolysis of NPP by the POM is proposed.

MagRET Nanoparticles: An Iron Oxide Nanocomposite Platform for Gene Silencing from MicroRNAs to Long Noncoding RNAs

Silencing of RNA to knock down genes is currently one of the top priorities in gene therapies for cancer. However, to become practical the obstacle of RNA delivery needs to be solved. In this study, we used innovative maghemite (γ-Fe2O3) nanoparticles, termed magnetic reagent for efficient transfection (MagRET), which are composed of a maghemite core that is surface-doped by lanthanide Ce(3/4+) cations using sonochemistry. Thereafter, a polycationic polyethylenimine (PEI) polymer phase is bound to the maghemite core via coordinative chemistry enabled by the [CeL(n)](3/4+)cations/complex. PEI oxidation was used to mitigate the in vivo toxicity. Using this approach, silencing of 80-100% was observed for mRNAs, microRNAs, and lncRNA in a variety of cancer cells. MagRET NPs are advantageous in hard to transfect leukemias. This versatile nanoscale carrier can silence all known types of RNAs and these MagRET NPs with oxidized PEI are not lethal upon injection, thus holding promise for therapeutic applications, as a theranostic tool.

Tuning Cerium(IV)-Assisted Hydrolysis of Phosphatidylcholine Liposomes under Mildly Acidic and Neutral Conditions

With the goal of designing a lysosomal phospholipase mimic, we optimized experimental variables to enhance Ce(IV) -assisted hydrolysis of phosphatidylcholine (PC) liposomes. Our best result was obtained with the chelating agent bis-tris propane (BTP). Similar to the hydrolytic enzyme, Ce(IV) -assisted hydrolysis of PC phosphate ester bonds was higher at lysosomal pH (∼4.8) compared to pH 7.2. In the presence of BTP, the average cleavage yield at ∼pH 4.8 and 37 °C was: 67±1 %, 5.7-fold higher than at ∼pH 7.2 and roughly equivalent to the percent of phospholipid found on the metal-accessible exo leaflet of small liposomes. No Ce(IV) precipitation was observed. When BTP was absent, there was significant turbidity, and the amount of cleavage at ∼pH 4.8 (69±1 %) was 2.1-fold higher than the yield obtained at ∼pH 7.2. Our results show that BTP generates homogenous solutions of Ce(IV) that hydrolyze phosphatidylcholine with enhanced selectivity for lysosomal pH.

The Yin: An adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicity

This critical review evolved from a SNO Special Workshop on Nanoceria panel presentation addressing the toxicological risks of nanoceria: accumulation, target organs, and issues of clearance; how exposure dose/concentration, exposure route, and experimental preparation/model influence the different reported effects of nanoceria; and how can safer by design concepts be applied to nanoceria? It focuses on the most relevant routes of human nanoceria exposure and uptake, disposition, persistence, and resultant adverse effects. The pulmonary, oral, dermal, and topical ocular exposure routes are addressed as well as the intravenous route, as the latter provides a reference for the pharmacokinetic fate of nanoceria once introduced into blood. Nanoceria reaching the blood is primarily distributed to mononuclear phagocytic system organs. Available data suggest nanoceria's distribution is not greatly affected by dose, shape, or dosing schedule. Significant attention has been paid to the inhalation exposure route. Nanoceria distribution from the lung to the rest of the body is less than 1% of the deposited dose, and from the gastrointestinal tract even less. Intracellular nanoceria and organ burdens persist for at least months, suggesting very slow clearance rates. The acute toxicity of nanoceria is very low. However, large/accumulated doses produce granuloma in the lung and liver, and fibrosis in the lung. Toxicity, including genotoxicity, increases with exposure time; the effects disappear slowly, possibly due to nanoceria's biopersistence. Nanoceria may exert toxicity through oxidative stress. Adverse effects seen at sites distal to exposure may be due to nanoceria translocation or released biomolecules. An example is elevated oxidative stress indicators in the brain, in the absence of appreciable brain nanoceria. Nanoceria may change its nature in biological environments and cause changes in biological molecules. Increased toxicity has been related to greater surface Ce3+, which becomes more relevant as particle size decreases and the ratio of surface area to volume increases. Given its biopersistence and resulting increased toxicity with time, there is a risk that long-term exposure to low nanoceria levels may eventually lead to adverse health effects. This critical review provides recommendations for research to resolve some of the many unknowns of nanoceria's fate and adverse effects.

An Anionic Surfactant Metallomicelle: Catalytic Activity and Mechanism for the Catalytic Hydrolysis of a Phosphate Ester

An aza-crown ether ligand was synthesised and characterised. The chemical composition of the binary complex containing cerium(III) and the ligand was determined by fluorescence spectroscopy. A new metallomicellar system comprising the cerium(III) complex of the ligand and an anionic micelle (n-lauroylsarcosine) was used as catalyst in the hydrolysis of bis(4-nitrophenyl) phosphate ester (BNPP). The catalytic rate of BNPP hydrolysis and the local concentration effect of the micelle were measured kinetically using UV-Vis spectrophotometry. The results indicated, that compared with a cationic metallomicelle system made from the aza-crown ether, lanthanum(III) ion and CTAB cationic surfactant in our previous report, the anionic metallomicelle exhibited a six-fold higher catalytic activity in BNPP hydrolysis at neutral pH and the same other conditions, thus the micelle based on LSS provides a more effective catalytic environment for reaction. A reaction mechanism has been proposed.

Framework and Catalytic Activity of a Metallomicelle System Made from an Azacrown Ether, Lanthanum(III) Ion and a Cationic Surfactant

A metallomicelle system comprising an azacrown ether, lanthanum(III) ion and a cationic surfactant was constructed and used as catalyst in the hydrolysis of bis(4-nitrophenyl) phosphate ester (BNPP). The interaction between La(III) and the azacrown ether, and the resulting complex and BNPP, were analysed by fluorescence spectroscopy. The catalytic rate of BNPP hydrolysis was measured kinetically by UV-Vis spectrophotometry. The results indicated that the metallomicelle system exhibited relatively high stability and excellent catalytic function in BNPP hydrolysis, the rate of which, compared with the spontaneous hydrolysis, increased by a factor of ca 2 × 107 due to the catalytic effect of the active species and the local concentration effect of the micelle in the metallomicellar system. The results also showed that the complex, comprising La(III) ion, and the azacrown ether, is the active catalytic species, while the micelles provide a useful catalytic environment for reaction. On the basis of these results, a reaction mechanism for the catalytic hydrolysis of BNPP is proposed.

Ce3/4+ cation-functionalized maghemite nanoparticles towards siRNA-mediated gene silencing

b-PEI₂₅-decorated [CeL_n]^3/4+-doped maghemite (γ-Fe₂O₃) nanoparticles were prepared for siRNA-mediated gene silencing using coordination chemistry as an inorganic way of functionalization.

Phosphate ester hydrolysis of biologically relevant molecules by cerium oxide nanoparticles

In an effort to characterize the interaction of cerium oxide nanoparticles (CNPs) in biological systems, we explored the reactivity of CNPs with the phosphate ester bonds of p-nitrophenylphosphate (pNPP), ATP, o-phospho-l-tyrosine, and DNA. The activity of the bond cleavage for pNPP at pH 7 is calculated to be 0.860 ± 0.010 nmol p-nitrophenol/min/μg CNPs. Interestingly, when CNPs bind to plasmid DNA, no cleavage products are detected. While cerium(IV) complexes generally exhibit the ability to break phosphorus-oxygen bonds, the reactions we report appear to be dependent on the availability of cerium(III) sites, not cerium(IV) sites. We investigated the dephosphorylation mechanism from the first principles and find the reaction proceeds through inversion of the phosphate group similar to an S(N)2 mechanism. The ability of CNPs to interact with phosphate ester bonds of biologically relevant molecules has important implications for their use as potential therapeutics.